Draft:Peter Timothy O'Heeron
| Submission declined on 11 September 2024 by Qcne (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: Interviews and press releases don't contribute to notability. Qcne (talk) 19:46, 11 September 2024 (UTC)
Peter Timothy O’Heeron | |
|---|---|
| Born | October 7, 1963 |
| Citizenship | American |
| Education | University of Chicago (Mergers & Acquisitions) University of Houston-Clear Lake (Master’s in Healthcare Administration) |
| Occupation | Executive/Inventor |
Peter (Pete) Timothy O’Heeron (born October 7, 1963) is an American businessperson, inventor, and executive in the biotechnology and medical technology industries. He is the Founder and Chief Executive Officer of FibroBiologics, a company focused on developing and commercializing fibroblast-based cell therapies.[1] O'Heeron holds over 350 patents issued and pending in biologics, cell therapy, and medical devices, making him one of the most prolific biopharma inventors of his generation.[2][3][4]
Early life and education
[edit]O'Heeron was born on October 7, 1963, to Michael Kinney O’Heeron and Judith Evelyn O’Neil. He was raised in Lake Jackson, Texas, and attended Brazoswood High School with current U.S. Senator Rand Paul and Bayer Pharma AG CEO Bill Anderson.[5] He pursued his undergraduate education at Texas State University, earning a degree in Healthcare Administration in 1986. He later obtained a Master's in Healthcare Administration from the University of Houston–Clear Lake in 1988. In 2017, O'Heeron completed an Executive Program in Mergers and Acquisitions at the University of Chicago.[6]
Career
[edit]O'Heeron began his career in the healthcare industry, gaining executive-level experience at Christus Health Care Corporation. He became a regional product development leader in sports medicine and optimization of physician practice management. In addition, O’Heeron has provided strategic advisory services to various healthcare companies, particularly in biologics, advanced surgical instrumentation, and telemedicine.[7]
In 2006, O'Heeron founded Advanced Medical Technologies, an operational investment group. One of his notable ventures was NeoSurg Technologies, which developed the T2000 Minimally Invasive Access System. The company was later sold to Cooper Surgical.[8]
O'Heeron founded FibroBiologics (formerly FibroGenesis, LLC), where he currently serves as CEO. Under his leadership, the company has focused on developing fibroblast-based cell therapies for treating chronic diseases.[9] His contributions to the field have accumulated over 350 patents in biologics, cell therapy, and medical devices.
O’Heeron took FibroBiologics public on the Nasdaq through a direct listing, which made it the first biopharma to achieve a listing on the Nasdaq Gloable Exchange through a direct listing.
O’Heeron has been involved in several notable ventures, including SpinalCyte, a company focused on spinal disc regeneration; Cold River Records, a country music record label[1]; and Christus Health. As of 2024, O’Heeron’s net worth is over $30 million.[10]
Personal life
[edit]O'Heeron married Dorothy Angela O’Heeron in August 1986, and they have three children, Conner, Parker, and Grace. Pete’s grandfather, Michael O’Heeron, M.D., was a world-renowned Urologist/Surgeon and one of the founders of the Urological Society of America.
References
[edit]- ^ a b Sherman, Bill (2023-10-03). "Taking New Ideas to Market | Pete O'Heeron". Thought Leadership Leverage. Retrieved 2024-09-10.
- ^ O’Heeron, Pete (2023-12-27). "Key Leadership Lessons for Biotech Executives from a Hospital Administrator". MedCity News. Retrieved 2024-09-10.
- ^ "Houston cell therapy company prepares to IPO, move into new facility - InnovationMap". houston.innovationmap.com. Retrieved 2024-09-10.
- ^ "| BioWorld". www.bioworld.com. Retrieved 2024-09-10.
- ^ "Interview with FibroBiologics CEO Pete O'Heeron". Health Business Group. Retrieved 2024-09-10.
- ^ "Fibroblasts In Regenerative Medicine With FibroBiologics' Pete O'Heeron & Dr. Hamid Khoja". www.lifescienceleader.com. Retrieved 2024-09-10.
- ^ "FibroBiologics goes public in direct listing". www.andrewjowett.net. Retrieved 2024-09-10.
- ^ "FibroBiologics goes public in direct listing". www.andrewjowett.net. Retrieved 2024-09-10.
- ^ "Pete O'heeron Acquires 8,500 Shares of FibroBiologics, Inc. (NASDAQ:FBLG) Stock". MarketBeat. Retrieved 2024-09-10.
- ^ "Pete O'Heeron Named 30 Best CEOs of 2020 and Lands at the #3 Spot on Silicon Review Magazine". Yahoo Finance. 2019-12-12. Retrieved 2024-09-10.